开盘$159.40
昨收$161.93
当日区间$159.36 – $163.11
成交量2.00M
市值$307.00B
市盈率（TTM）31.0
股息率2.92%
NVS 相关新闻
匹配 Novartis AG 或代码 NVS 的头条新闻，按最新排序。
- TD Cowen Maintains Novartis AG(NVS.US) With Hold Rating, Maintains Target Price $180
- Strong sales of innovative drugs offset the impact from generics! Novartis AG (NVS.US) Q2 results beat expectations, signaling a return to growth trajectory. 正面
- TD Cowen Maintains Novartis AG(NVS.US) With Hold Rating, Maintains Target Price $180
- Setback for the second time in a week! Novartis (NVS.US) sees its blockbuster heart disease drug fail in Phase III trials, causing a sharp drop in share price; Amgen (AMGN.US) suffers collateral damage. 负面
- BofA Securities Maintains Novartis AG(NVS.US) With Buy Rating, Raises Target Price to $185.56 正面
- BofA Securities Maintains Novartis AG(NVS.US) With Buy Rating, Announces Target Price $172.96
- Novartis AG (NVS.US) secures approval in China for a new indication for its blockbuster radiopharmaceutical 正面
- BofA Securities Maintains Novartis AG(NVS.US) With Buy Rating
- Argus Research Initiates Novartis AG(NVS.US) With Buy Rating, Announces Target Price $160
- TD Cowen Maintains Novartis AG(NVS.US) With Hold Rating, Raises Target Price to $180 正面
- BofA Securities Maintains Novartis AG(NVS.US) With Buy Rating, Raises Target Price to $177.37 正面
- BofA Securities Maintains Novartis AG(NVS.US) With Buy Rating, Cuts Target Price to $175.32 负面
- Morgan Stanley Maintains Novartis AG(NVS.US) With Buy Rating, Raises Target Price to $170 正面
- BofA Securities Maintains Novartis AG(NVS.US) With Buy Rating, Cuts Target Price to $177.61 负面
- BofA Securities Upgrades Novartis AG(NVS.US) to Buy Rating, Raises Target Price to $177.65 正面
暂无评论——快来第一个聊聊 NVS。
登录后参与讨论。